Schneider EM - Search Results

1

High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation.

Einsele H, Ehninger G, Schneider EM, Krüger GF, Vallbracht A, Dopfer R, Schmidt H, Waller HD, Müller CA. Einsele H, et al. Among authors: schneider em. Transplantation. 1988 Mar;45(3):579-85. doi: 10.1097/00007890-198803000-00016. Transplantation. 1988. PMID: 3279584

2

Distinct types of donor and recipient T cell clones functionally related to host-v-graft reactivity and autologous remission after bone marrow transplantation for severe aplastic anemia.

Schneider EM, Pawelec G, Haen M, Ehninger G, Ostendorf P, Kömpf J, Schöllhorn V, Wernet P. Schneider EM, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2620-5. Transplant Proc. 1987. PMID: 2950637 No abstract available.

3

Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon).

Pawelec G, Schneider E, Ehninger G, Rehbein A, Schmidt H. Pawelec G, et al. Cancer Immunol Immunother. 1989;29(1):63-6. doi: 10.1007/BF00199918. Cancer Immunol Immunother. 1989. PMID: 2785001 Free PMC article.

4

Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapy.

Pawelec G, Schmidt H, Schneider E, Bühring HJ, Ehninger G. Pawelec G, et al. Cancer Immunol Immunother. 1988;27(1):89-94. doi: 10.1007/BF00205764. Cancer Immunol Immunother. 1988. PMID: 2969285 Free PMC article.

5

Human leukocyte antigen-DP in leukemia.

Pawelec G, Ehninger G, Müller C, Blaurock M, Schneider EM, Wernet P. Pawelec G, et al. Among authors: schneider em. Cancer. 1988 Feb 1;61(3):475-7. doi: 10.1002/1097-0142(19880201)61:3<475::aid-cncr2820610311>3.0.co;2-m. Cancer. 1988. PMID: 3422171

6

Autoreactive T cells isolated during graft-versus-host disease (GvHD) may be involved in the generation of an anti-leukemic effect after bone marrow transplantation (BMT).

Schneider EM, Dörre S, Wernet P. Schneider EM, et al. Transplant Proc. 1989 Feb;21(1 Pt 3):3018-21. Transplant Proc. 1989. PMID: 2650416 No abstract available.

7

Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: effects on cytokine production and suppressor cell status.

Pawelec G, Lenz HJ, Schneider E, Bühring HJ, Rehbein A, Baumgärtner P, Ehninger G. Pawelec G, et al. Biotherapy. 1991;3(4):309-18. doi: 10.1007/BF02221323. Biotherapy. 1991. PMID: 1838486 Clinical Trial.

8

Lymphokine release, suppressor cell generation, cell surface markers, and cytotoxic activity in cancer patients receiving natural interleukin-2.

Pawelec G, Schwuléra U, Lenz H, Owsianowski M, Bühring HJ, Schlag H, Schneider E, Schaudt K, Ehninger G. Pawelec G, et al. Mol Biother. 1990 Mar;2(1):44-9. Mol Biother. 1990. PMID: 2139787

9

High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.

Schneider EM, Dörries K. Schneider EM, et al. Transplant Proc. 1993 Feb;25(1 Pt 2):1271-3. Transplant Proc. 1993. PMID: 8382856 No abstract available.

10

HTLV-I-related agent and non-Hodgkin lymphomas in married couple.

Saal JG, Schneider EM, Müller C, Waller HD. Saal JG, et al. Among authors: schneider em. Lancet. 1987 Mar 21;1(8534):686-7. doi: 10.1016/s0140-6736(87)90448-x. Lancet. 1987. PMID: 2882105 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters